Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Abbott Laboratories (ABT) had Debt to Capital Ratio of 0.26 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$40.11B |
|
$5.72B |
|
$17.98B |
|
$22.13B |
|
$33.63B |
|
$6.48B |
|
$186.00M |
|
$6.66B |
|
$6.66B |
|
$5.72B |
|
$5.72B |
|
$5.72B |
|
$5.72B |
|
$6.48B |
|
$9.72B |
|
1.74B |
|
1.75B |
|
$3.28 |
|
$3.26 |
|
| Balance Sheet Financials | |
$22.67B |
|
$10.15B |
|
$50.54B |
|
$73.21B |
|
$13.84B |
|
$13.60B |
|
$20.55B |
|
$34.39B |
|
$38.83B |
|
$6.33B |
|
$38.83B |
|
1.73B |
|
| Cash Flow Statement Financials | |
$7.26B |
|
$-3.13B |
|
$-7.09B |
|
$9.88B |
|
$6.90B |
|
$-2.99B |
|
$644.00M |
|
$-3.56B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.64 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.26 |
0.38 |
|
55.18% |
|
16.15% |
|
16.15% |
|
24.24% |
|
16.61% |
|
14.27% |
|
$5.06B |
|
-- |
|
-- |
|
-- |
|
0.55 |
|
2.74 |
|
6.11 |
|
59.74 |
|
14.74% |
|
90.37% |
|
7.82% |
|
10.92% |
|
$22.39 |
|
$2.89 |
|
$4.15 |
|